Literature DB >> 22281876

Clinical and genetic features of hereditary periodic fever syndromes in Hispanic patients: the Chilean experience.

Cristian Vergara1, Arturo Borzutzky, Miguel A Gutierrez, Sergio Iacobelli, Eduardo Talesnik, María E Martinez, Lilith Stange, Javier Basualdo, Viviana Maluje, Renato Jimenez, Roberto Wiener, Javier Tinoco, Elena Jarpa, Juan I Aróstegui, Jordi Yagüe, Manuel Alvarez-Lobos.   

Abstract

Hereditary periodic fever syndromes (HPFS) are rare genetic diseases characterized by recurrent episodes of inflammation. Little information is available concerning HPFS in Latin American Hispanic population. The purpose of this study was to determine the clinical and genetic features of HPFS in Chilean population. A multicenter retrospective study of Hispanic Chilean patients with genetically confirmed HPFS was performed. We included 13 patients, 8 with familial Mediterranean fever (FMF) and 5 with TNF receptor-associated periodic syndrome (TRAPS), evaluated at rheumatology or pediatric rheumatology clinics between January 2007 and December 2010. Median age of symptoms onset was 8 years (range 1-35) and 8 years (range 0.3-21) for FMF and TRAPS, respectively. Median duration of fever was 3 days (range 2.5-15) for FMF and 21 days (range 9.5-30) for TRAPS. Genotyping of the MEFV gene in FMF patients revealed a homozygous M694V missense mutation in one patient, and heterozygous missense mutations in seven patients: M694V (n = 3), E148Q, R717H, A744S, and A511V. Sequencing of the TNFRSF1A gene in TRAPS patients revealed heterozygous missense mutations in four patients: T50M, C30R, R92Q, and IVS3+30:G→A, and a two-base pair deletion (IVS2-17_18del2bpCT) in one patient. Mutation in MEFV R717H and mutations in TNFRSF1A IVS2-17_18del2bpCT and IVS3+30:G→A are novel and have not been described previously. This study reports the largest series of genetically confirmed HPFS in Latin America, and adds evidence regarding the clinical and genetic characteristics of patients with FMF and TRAPS in Hispanic population. Mutations identified in MEFV and TNFRSF1A genes include defects reported in other ethnicities and novel mutations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22281876     DOI: 10.1007/s10067-012-1942-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  31 in total

1.  Expansion of CD28-CD27-NKG2D+ effector memory T cells and predominant Th1-type response during febrile attacks in tumor necrosis factor-associated periodic syndrome.

Authors:  Julia U Holle; Dorin Capraru; Elena Csernok; Wolfgang L Gross; Peter Lamprecht
Journal:  Isr Med Assoc J       Date:  2006-02       Impact factor: 0.892

2.  Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice.

Authors:  Jae Jin Chae; Young-Hun Cho; Geun-Shik Lee; Jun Cheng; P Paul Liu; Lionel Feigenbaum; Stephen I Katz; Daniel L Kastner
Journal:  Immunity       Date:  2011-05-19       Impact factor: 31.745

3.  Familial Mediterranean Fever in Armenians. Analysis of 100 cases.

Authors:  A D Schwabe; R S Peters
Journal:  Medicine (Baltimore)       Date:  1974-11       Impact factor: 1.889

4.  Autoinflammatory disease reloaded: a clinical perspective.

Authors:  Daniel L Kastner; Ivona Aksentijevich; Raphaela Goldbach-Mansky
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

5.  Autoinflammatory syndromes: report on three cases.

Authors:  Thais Cunha Matos; Maria Teresa Ramos Ascensão Terreri; Daniela Gerent Petry; Cássia Maria Barbosa; Claudio Arnaldo Len; Maria Odete Esteves Hilário
Journal:  Sao Paulo Med J       Date:  2009-09       Impact factor: 1.044

Review 6.  Therapy of autoinflammatory syndromes.

Authors:  Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

7.  The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome.

Authors:  Catherine Dodé; Marc André; Thierry Bienvenu; Pierre Hausfater; Christophe Pêcheux; Jacques Bienvenu; Jean-Claude Lecron; Philippe Reinert; Daniel Cattan; Jean-Charles Piette; Marie-France Szajnert; Marc Delpech; Gilles Grateau
Journal:  Arthritis Rheum       Date:  2002-08

8.  Familial Hibernian fever.

Authors:  L M Williamson; D Hull; R Mehta; W G Reeves; B H Robinson; P J Toghill
Journal:  Q J Med       Date:  1982

9.  Familial Mediterranean fever with a single MEFV mutation: where is the second hit?

Authors:  Matthew G Booty; Jae Jin Chae; Seth L Masters; Elaine F Remmers; Beverly Barham; Julie M Le; Karyl S Barron; Steve M Holland; Daniel L Kastner; Ivona Aksentijevich
Journal:  Arthritis Rheum       Date:  2009-06

Review 10.  [Hereditary systemic autoinflammatory diseases. Hereditary periodic fever syndromes].

Authors:  Juan I Aróstegui; Jordi Yagüe
Journal:  Med Clin (Barc)       Date:  2007-07-14       Impact factor: 1.725

View more
  3 in total

Review 1.  Tumor necrosis factor-associated periodic syndrome in adults.

Authors:  Sharika Gopakumar Menon; Petros Efthimiou
Journal:  Rheumatol Int       Date:  2017-09-23       Impact factor: 2.631

2.  The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist.

Authors:  Micol Romano; Z Serap Arici; David Piskin; Sara Alehashemi; Daniel Aletaha; Karyl Barron; Susanne Benseler; Roberta A Berard; Lori Broderick; Fatma Dedeoglu; Michelle Diebold; Karen Durrant; Polly Ferguson; Dirk Foell; Jonathan S Hausmann; Olcay Y Jones; Daniel Kastner; Helen J Lachmann; Ronald M Laxer; Dorelia Rivera; Nicola Ruperto; Anna Simon; Marinka Twilt; Joost Frenkel; Hal M Hoffman; Adriana A de Jesus; Jasmin B Kuemmerle-Deschner; Seza Ozen; Marco Gattorno; Raphaela Goldbach-Mansky; Erkan Demirkaya
Journal:  Arthritis Rheumatol       Date:  2022-05-27       Impact factor: 15.483

3.  Analysis of the Most Common Three MEFV Mutations in 630 Patients with Familial Mediterranean Fever in Iranian Azeri Turkish Population.

Authors:  Morteza Bagheri; Isa Abdi Rad
Journal:  Maedica (Bucur)       Date:  2017-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.